Skip to content

Turkish of the SARS-CoV-2 Anxiety Scale

Turkish Validity And Reliability of the SARS-CoV-2 Anxiety Scale

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04490473
Enrollment
300
Registered
2020-07-29
Start date
2020-07-24
Completion date
2021-04-24
Last updated
2020-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, SARS-CoV Infection

Keywords

Coronavirus Anxiety Scale, COVID-19, Anxiety

Brief summary

The coronavirus outbreak has adversely affected individuals in the community, as in the rest of the world. However, in order to carry out this epidemic period in a healthy and conscious manner, determining the anxiety levels of individuals in the society and supporting them psychologically is of great importance. In order to achieve this, healthcare professionals working clinically or academically have important duties. This study was planned to test its validity and reliability in order to adapt the Coronavirus Anxiety Scale to Turkish.

Detailed description

Coronaviruses can be seen in animals and humans as infections that can be mild and severe in society. The SARS-CoV-2 virus, a type of coronavirus, started in China in December 2019 and has spread worldwide as of January 2020. The absence of vaccine and treatment for SARS-CoV-2 disease threatens health worldwide and significantly affects people's daily routine. In China, where the pandemic started, shopping malls and schools were closed for a while, and city entrances and exits were stopped for a while. Although there are similar practices in excellence, as in many countries, measures such as curfew, nursery and school closure continue to be taken for under-20s and over-65s. . The coronavirus epidemic that affects our entire life is not fully known about the disease process, WHO is defined as the pandemic of the epidemic, the nearest contact is the greatest risk of transmission, and the loss of many lives during this process affects all individuals in the society negatively and increases the level of anxiety . It is a psychological reaction involving many emotions such as anxiety, stress, or anxiety, fear and distress that arise in a situation that threatens the safety of the individual. Conditions such as uncertainty, various diseases (cancer, epidemic, etc.) and losing a relative can cause anxiety. Outbreaks that occur suddenly and are at risk of death are among these reasons.

Interventions

Survey forms will be sent to individuals online. Information about the study will be given to individuals with the informative text at the beginning of the questionnaire form. Individuals who agree to participate in the study will fill in the questionnaire and send it back online.

Sponsors

DILEK SAYIK
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

This research will be conducted in a methodological manner in order to conduct the validity and reliability studies of the Coronary Virus Anxiety Scale in Turkish.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

; * individuals agree to participate in the study * 18 years old, * Lack of visual obstacle, * Knowing how to speak, read and write in Turkish.

Exclusion criteria

; * individuals refuse to participate in the study * 18 years old, * Visually impaired, * Does not know how to speak, read and write in Turkish

Design outcomes

Primary

MeasureTime frameDescription
Anxiety in SARS-CoV-24 weeksanxiety increase in SARS-CoV-2 in humans.
Ratio of SARS-CoV-2 anxiety scale to beck anxiety scale4 weeksThe ratio of SARS-CoV-2 anxiety scale to beck anxiety scale is similar.

Countries

Turkey (Türkiye)

Contacts

Primary ContactDILEK SAYIK
dileksayik@hotmail.com5065416642
Backup ContactDENIZ YIGIT
yigitdenizyigit@gmail.com05428092848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026